Stay updated on Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Sign up to get notified when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.

Latest updates to the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label on the page is updated from v3.5.3 to v3.5.4, indicating a small platform-level update rather than changes to study content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.5.3 instead of Revision: v3.5.2, indicating a newer release version of the site. This update reflects the refreshed interface/content without altering any study information or user tasks.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. The page now displays the new revision version.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded a new trial site entry for Santiago Metropolitan, Chile (Santiago, 8330074) and updated the locations list. Removed the previous Santiago, Chile entry and added a Plain Language Trial Summary accessible at novctrd.com.SummaryDifference0.3%

- Check70 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor software version update with no visible changes to the study content or layout.SummaryDifference0.0%

Stay in the know with updates to Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.